Editorial Guide updates July 2017
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

View only
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACADAEAFAG
1
Attribute
2
Subject HierarchySectionAdded Removed Expanded RangeComments
3
Imported Extension ID Addition to guidance on management of local identifiers7.3.9
4
Conjunction and disjunctionExplanation7.2.14
5
Defining attributes Observable entity; new attributes added5.1.1Using access device
Characterizes
Direct site
Has realization
Inherent location
Inheres in
Precondition
Process agent
Process duration
Process output
Property type
Relative to
Relative to part of
Scale typeTechnique
Time aspect
Towards
Units
Using device
6
Defining attributes Pharmaceutical / biologic product5.1.1Has basis of strength substance
Has manufactured dose form
Has presentation strength numerator value
Has presentation strength numerator unit
Has presentation strength denominator value
Has presentation strength denominator unit
7
Defining attributes Substance5.1.2Has disposition<< |Disposition|
8
Defining attributes Anatomical structure5.1.1Part of
9
Defining attributes; Historical relationships Removed WAS A - no longer a valid inactivation reason.5.1.1WAS A
10
New attribute and valuesClinical Finding5.1.1Has Interpretation<< |Colors (qualifier value)|
11
New attribute and valuesClinical Finding5.1.2Finding Informer<< |Person with characteristic related to subject of record|
12
New attribute and valuesClinical Finding5.1.1During AND/OR After<< |Clinical finding|
<< |Procedure|
13
New attribute and valuesClinical Finding5.1.1During<< |Procedure|
14
New attribute and valuesClinical Finding5.1.1Before << |Procedure|
15
New attribute and valuesClinical Finding5.1.1Temporally related to<< |Clinical finding|
<< |Procedure|
16
New attribute and valuesClinical Finding5.1.1Pathological process<< |Pathological developmental process (qualifier value)|
17
Defining attributes Deprecation of attribute 5.1.1Has definitional manifestationNilShould not be applied to new concepts or when changes to a concept are made. Deprecation planned for January 2018.
18
New attribute and valuesPharmaceutical / Biologic Product5.1.1
5.1.2
Has presentation strength denominator unit < |Unit (qualifier value)|
19
New attribute and valuesPharmaceutical / Biologic Product5.1.1
5.1.2
Has manufactured dose form Type of drug preparation
20
New attribute and valuesPharmaceutical / Biologic Product5.1.1
5.1.2
Has presentation strength numerator value < |Number (qualifier value)|
21
New attribute and valuesPharmaceutical / Biologic Product5.1.1
5.1.2
Has presentation strength numerator unit N/A - future
22
New attribute and valuesPharmaceutical / Biologic Product5.1.1
5.1.2
Has presentation strength denominator value < |Number (qualifier value)|
23
New attribute and valuesPharmaceutical / Biologic Product5.1.1
5.1.2
Has presentation strength denominator unit N/A - future
24
Defining attributes Administration of substance via specific route (procedure)5.1.1
5.1.2
Route of administration
25
ProcedureExpansion of range5.1.2Has intent<< |Intents (nature of procedure values)| drawn from the Qualifier Value hierarchy
26
SubstanceNew attribute and values5.2Has disposition <|Disposition (disposition)| drawn from the Qualifier Value hierarchy
27
GuidanceALL - FSN matching synonym 7.3.2Matching synonym no longer mandatory
28
GuidanceALL - Target values9.2
29
GuidanceALL - Inactivation; use of the WAS A historical relationshipWAS AN/ANow only for use with a limited status concept. Please see Section
30
GuidanceALL = Proximal primitive modelling7.2.12
31
Clinical FindingUpdate to guidance for disorder combinations 6.15Focuses on complications and sequelae.
32
ProcedureUpdate to guidance for imaging procedures using contrast. 7.8.11
33
ProcedureEvaluation proceduresClarified use of attributes
34
Assessment ScalesAssessment scalesGuidance added
35
General Punctuation guidance change 7.2.2Use of commas in FSNs.
36
Pharmaceutical / Biologic ProductPharmaceutical Use of proprietary
37
LOINC terms6.1.3Link to mapping and modelling guidelines added
38
Body StructureAnatomical structure6.5Unilateral concepts are no longer accepted.
39
GeneralChanges and guidance for description inactivation values.7.1.5. New concepts added and guidance on use provided.
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
Loading...
Main menu